Sidley Austin LLP’s Meena Datta told HealthLeaders that the Centers for Medicare and Medicaid Services’ (CMS) latest proposal is a “grab-bag of issues.”
Datta said the proposal, which looks to ease regulations on value-based deals, addresses issues for which the health industry has long sought guidance.
“I think that this signals a positive sign for providers, with respect to so called VBP arrangements and reflects the potential for increased flexibility for manufacturers to offer these VBP arrangements,” Datta said. “To that end, what the marketplace could see, particularly institutional providers or other providers that purchase drugs from pharmaceutical manufacturers, is additional flexibility for the types of commercial arrangements that could be entered into that allow the parties to negotiate drug prices based on value instead of the volume purchase.”
To read the full report on HealthLeaders, click here.